Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Identification of Predictive Markers of Severe and Prolonged Neutropenia after CD19-Specific CAR T-Cell Treatment in Patients with Relapsed/Refractory B-Cell Malignancies

Kai Rejeski, MD, Carolina Berger, Liv Jentzsch, Semjon Willier, MD, Viktoria Blumenberg, MD, Veit Buecklein, MD, Christoph Faul, MD, Christian Schmidt, MD, Michael von Bergwelt, MD PhD, Tobias Feuchtinger, MD, Wolfgang Bethge, MD, Francis A. Ayuk, Marion Subklewe, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-141833

Published: 2020

Journal Articles

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

Gabriele Escherich, MD, Udo Zur Stadt, PhD, Dagmar Dilloo, MD, Joerg Faber, MD PhD, Tobias Feuchtinger, MD, Thomas Imscheiler, MD, Norbert Jorch, MD, Arnulf Pekrun, Irene Schmid, MD, Martin Zimmermann, PhD, Martin A. Horstmann, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-136149

Published: 2020

Journal Articles

TIM-3 Expression on CD4 + Bone Marrow T Cells Predicts Relapse of Pediatric B-Precursor Acute Lymphoblastic Leukemia

Franziska Blaeschke, MD, Semjon Willier, MD, Dana Stenger, Mareike Lepenies, Martin A. Horstmann, MD, Gabriele Escherich, Martin Zimmermann, PhD, Theresa Kaeuferle, PhD, Meino Rohlfs, PhD, Irene Schmid, MD, Michael H. Albert, MD, Vera Binder, MD, Christoph Klein, MD PhD, Tobias Feuchtinger, MD

Blood (2018) 132 (Supplement 1): 2833.

https://doi.org/10.1182/blood-2018-99-118376

Published: 2018

Journal Articles

Bone Marrow T Cells Are Driven into Exhaustion By Acute Leukemia in Pediatric Patients Based on Protein and Transcriptome Analysis

Semjon Willier, MD, Paula Rothaemel, Jonas Wilhelm, Dana Stenger, Theresa Kaeuferle, PhD, Irene Schmid, MD, Michael H. Albert, MD, Vera Binder, MD, Meino Rohlfs, PhD, Sebastian Hollizeck, Christoph Klein, MD PhD, Franziska Blaeschke, MD, Tobias Feuchtinger, MD

Blood (2018) 132 (Supplement 1): 3722.

https://doi.org/10.1182/blood-2018-99-112811

Published: 2018

Journal Articles

Defined Central Memory and Stem Memory T Cell Phenotype of CD4 and CD8 CAR T Cells for the Treatment of CD19+ Acute Lymphoblastic Leukemia in an Automated Closed System

Franziska Blaeschke, MD, Theresa Kaeuferle, PhD, Judith Feucht, MD, Dana Weber, Ramin Lotfi, MD, Andrew Kaiser, PhD, Mario Assenmacher, PhD, Michaela Doering, MD, Tobias Feuchtinger, MD

Blood (2016) 128 (22): 4558.

https://doi.org/10.1182/blood.V128.22.4558.4558

Published: 2016

Journal Articles

Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab

Tobias Feuchtinger, MD, Judith Feucht, MD, Simone Kayser, David Gorodezki, Michaela Döring, MD, Franziska Blaeschke, MD, Hans Bösmüller, MD, Leticia Quintanilla-Fend, Prof. Dr., Patrick Schlegel, MD, Martin Ebinger, Peter J. Lang, MD, Rupert Handgretinger, MD

Blood (2015) 126 (23): 3764.

https://doi.org/10.1182/blood.V126.23.3764.3764

Published: 2015

Journal Articles

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Michaela Döring, MD, Karin Melanie Cabanillas Stanchi, Manon Queudeville, MD, Judith Feucht, MD, Patrick Schlegel, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Prof. MD, Werner J. Heinz, MD

Blood (2015) 126 (23): 4338.

https://doi.org/10.1182/blood.V126.23.4338.4338

Published: 2015

Journal Articles

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Wolfgang Schwinger, MD, Patrick Schlegel, MD, Michael Schumm, DVM, Anne-Marie Lang, Barbara Lang, MD, Carl Philipp Schwarze, MD, Martin Ebinger, MD, Christian E. Urban, MD, Rupert Handgretinger

Blood (2014) 124 (21): 852.

https://doi.org/10.1182/blood.V124.21.852.852

Published: 2014

Journal Articles

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Michael Schumm, DVM, Patrick Schlegel, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Carl-Philipp Schwarze, MD, Rupert Handgretinger

Blood (2013) 122 (21): 692.

https://doi.org/10.1182/blood.V122.21.692.692

Published: 2013

Journal Articles

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Matthias Pfeiffer, Ingo Mueller, Andre Schrauder, MD, Rupert Handgretinger, Peter Lang, MD

Blood (2013) 122 (21): 4573.

https://doi.org/10.1182/blood.V122.21.4573.4573

Published: 2013

Journal Articles

Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation

Katharina Reinhardt, Dirk Föll, MD, Thomas Vogl, PhD, Falko Fend, MD, Christian Gille, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Wolfgang A. Bethge, MD, Ursula Holzer, MD

Blood (2013) 122 (21): 2058.

https://doi.org/10.1182/blood.V122.21.2058.2058

Published: 2013

Journal Articles

Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors,

Lena Oevermann, MD, Sebastian Michaelis, cand.med., Markus Mezger, PhD, Matthias Pfeiffer, MD, Peter Lang, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2011) 118 (21): 4133.

https://doi.org/10.1182/blood.V118.21.4133.4133

Published: 2011

Journal Articles

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Peter J. Lang, MD, Matthias Pfeiffer, MD, Heiko-Manuel Teltschik, MD, Ingo Mueller, MD, Tobias Feuchtinger, MD, Michael Schumm, MD, Rupert Handgretinger, MD

Blood (2008) 112 (11): 2907.

https://doi.org/10.1182/blood.V112.11.2907.2907

Published: 2008

Journal Articles

Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

Roland Meisel, MD, Lisa Kuypers, Bernd Gruhn, MD, Gabi Strauss, MD, Brigitte Strahm, MD, Karoline Ehlert, MD, Karin Beutel, MD, Wolfgang Holter, MD, Renate Bluetters-Sawatzki, MD, Tobias Feuchtinger, MD, Hans-Peter Gruettner, MD, Ralf Schubert, PhD, Sabine Diedrich, MD, Marion Riffelmann, MD, Hans-Juergen Laws, MD, Dagmar Dilloo, MD

Blood (2007) 110 (11): 164.

https://doi.org/10.1182/blood.V110.11.164.164

Published: 2007

Journal Articles

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Peter J. Lang, MD, Ingo Mueller, MD, Heiko Teltschik, MD, Matthias Pfeiffer, MD, Martin Ebinger, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2007) 110 (11): 3019.

https://doi.org/10.1182/blood.V110.11.3019.3019

Published: 2007

Journal Articles

Quantitative HLA Class I Expression and KIR-Mismatch between NK-Cell-Donor and Patient Predict NK Cell Mediated Lysis of Leukemic Cells from Children with Acute Lymphatic Leukemia.

Matthias M. Pfeiffer, MD, Michael Schumm, Klaus Dietz, Tobias Feuchtinger, MD, Rupert Handgretinger, MD, Peter J. Lang, MD

Blood (2006) 108 (11): 5205.

https://doi.org/10.1182/blood.V108.11.5205.5205

Published: 2006

Journal Articles

Alloreactivity of Natural Killer Cell Clones Against Childhood Precursor-B Lymphoblastic Leukemia Cells Is Determined by Differential KIR Expression.

Tobias Feuchtinger, MD, Matthias Pfeiffer, MD, Alexander Pfaffle, MD, Heiko-Manuel Telschik, MD, Rupert Handgretinger, MD, Dorothee Wernet, MD, Michael Schumm, MD, Ramin Lotfi, MD, Peter Lang, MD

Blood (2006) 108 (11): 3691.

https://doi.org/10.1182/blood.V108.11.3691.3691

Published: 2006

Journal Articles

CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study.

Peter J. Lang, MD, Ingo Mueller, MD, Johann Greill, MD, Peter Bader, MD, Michael Schumm, Dr. med. vet., Matthias Pfeiffer, MD, Tobias Feuchtinger, MD, Rupert Handgretinger, MD

Blood (2006) 108 (11): 3121.

https://doi.org/10.1182/blood.V108.11.3121.3121

Published: 2006

Journal Articles

Hexon Specific T-Cells for Adoptive T-Cell Transfer as a Treatment of Adenovirus Infection after Allogeneic Stem Cell Transplantation.

Tobias Feuchtinger, MD, Celine Richard, Rupert Handgretinger, MD, Christiane Braun, Michael Schumm, Peter Lang, MD

Blood (2006) 108 (11): 2853.

https://doi.org/10.1182/blood.V108.11.2853.2853

Published: 2006

Journal Articles

Transplantation of Positive Selected Peripheral Stem Cells with Add-Back of T Cells from Unrelated Donors in Children: Favourable Survival and Low Incidence of GvHD.

Peter J. Lang, MD, Johann Greil, MD, Peter Bader, MD, Ulrike Mura, Michael Schumm, med. vet, Tobias Feuchtinger, MD, Matthias Pfeiffer, MD, Rupert Handgretinger, MD

Blood (2006) 108 (11): 2900.

https://doi.org/10.1182/blood.V108.11.2900.2900

Published: 2006

NARROW

Identification of Predictive Markers of Severe and Prolonged Neutropenia after CD19-Specific CAR T-Cell Treatment in Patients with Relapsed/Refractory B-Cell Malignancies

Clofarabine Significantly Increases Eradication of Minimal Residual Disease of B-Precursor ALL Compared to High-Dose Cytarabine in Randomized Trial Coall 08-09

TIM-3 Expression on CD4 + Bone Marrow T Cells Predicts Relapse of Pediatric B-Precursor Acute Lymphoblastic Leukemia

Bone Marrow T Cells Are Driven into Exhaustion By Acute Leukemia in Pediatric Patients Based on Protein and Transcriptome Analysis

Defined Central Memory and Stem Memory T Cell Phenotype of CD4 and CD8 CAR T Cells for the Treatment of CD19+ Acute Lymphoblastic Leukemia in an Automated Closed System

Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results

Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts

Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation

Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors,

Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation

Coadministration of the Hexavalent Combination Vaccine Infanrix hexa™ and the Pneumoccoccal Conjugate Vaccine Prevenar™ Provides Early and Comprehensive Vaccination Coverage in Children after Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease.

Quantitative HLA Class I Expression and KIR-Mismatch between NK-Cell-Donor and Patient Predict NK Cell Mediated Lysis of Leukemic Cells from Children with Acute Lymphatic Leukemia.

Alloreactivity of Natural Killer Cell Clones Against Childhood Precursor-B Lymphoblastic Leukemia Cells Is Determined by Differential KIR Expression.

CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study.

Hexon Specific T-Cells for Adoptive T-Cell Transfer as a Treatment of Adenovirus Infection after Allogeneic Stem Cell Transplantation.

Transplantation of Positive Selected Peripheral Stem Cells with Add-Back of T Cells from Unrelated Donors in Children: Favourable Survival and Low Incidence of GvHD.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only